This Article Free Full Text (Free PDF) Free References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Jugdutt, B. I Articles by Balghith, M. Search for Related Content PubMed PubMed Citation Articles by Jugdutt, B. I Articles by Balghith, M. Social Bookmarking                   What's this?

Enhanced regional AT2-receptor and PKC expression during cardioprotection induced by AT1-receptor blockade after reperfused myocardial infarction

Cardiology Division, Department of Medicine, University of Alberta, Edmonton, Alberta, bjugdutt{at}ualberta.ca

Mohammed Balghith

Cardiology Division, Department of Medicine, University of Alberta, Edmonton, Alberta

We assessed the effects of the angiotensin II (Ang II) type 1 receptor (AT₁-receptor) blocker, candesartan, (CN, 1 mg/kg i.v. over 30 minutes pre-ischaemia) alone or after intracoronary administration of Ang II type 2 receptor (AT ₂-receptor) blocker (PD 123319), protein kinase C (PKC) inhibitor (chelerythrine), endothelial nitric oxide (NO) synthase inhibitor (N^G-monomethyl-L-arginine or L-NMMA), and bradykinin (BK) -B₂ receptor inhibitor (HOE140) on in vivo left ventricular (LV) function and remodelling (echocardiograms/ Doppler) and haemodynamics in 30 dogs with reperfused anterior infarction (90 minutes ischaemia, 120 minutes reperfusion), and ex vivo infarct size, AT₁-receptor/AT₂-receptor proteins and PKC (immunoblots), and cyclic guanosine 3', 5' monophosphate (cGMP, immunoassay). Compared with controls, CN inhibited the Ang II pressor response, reduced LV preload, improved LV systolic and diastolic function, limited LV remodelling, decreased infarct size, and increased AT₂-receptor and PKC proteins in the infarct zone (IZ), and these responses were abrogated by PD 123319, chelerythrine, L-NMMA and HOE140. In addition, the increase in LV cGMP with CN was attenuated by PD 123319, L-NMMA and HOE140. The overall results suggest that AT₂-receptor activation and signalling via BK, PKC and cGMP contribute to cardioprotection associated with AT₁-receptor blockade during ischaemia-reperfusion injury.

Key Words: AT1-receptor • AT2-receptor • PKC • cGMP • ischaemia-reperfusion

Journal of Renin-Angiotensin-Aldosterone System, Vol. 2, No. 2, 134-140 (2001)
DOI: 10.3317/jraas.2001.015


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				D. Kumar, V. Menon, W. R. Ford, A. S. Clanachan, and B. I. Jugdutt Effect of Angiotensin II lype 2 Receptor Blockade on Activation of Mitogen-Activated Protein Kinases after Ischemia-Reperfusion in Isolated Working Rat Hearts Journal of Cardiovascular Pharmacology and Therapeutics, December 1, 2003; 8(4): 285 - 296. [Abstract] [PDF]

				B. I. Jugdutt and V. Menon Upregulation of Angiotensin II Type 2 Receptor and Limitation of Myocardial Stunning by Angiotensin II Type 1 Receptor Blockers during Reperfused Myocardial Infarction in the Rat Journal of Cardiovascular Pharmacology and Therapeutics, September 1, 2003; 8(3): 217 - 226. [Abstract] [PDF]